[Effect of spirazidin on the general nonspecific resistance of the organism].
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001835:Body Weight / Q000187:drug effects; D003864:Depression, Chemical; D008297:Male; D009929:Organ Size; D010587:Phagocytosis / Q000187:drug effects*; D051381:Rats; D012509:Sarcoma / Q000188:drug therapy*; D013141:Spiro Compounds / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D013154:Spleen / Q000033:anatomy & histology / Q000187:drug effects; D013268:Stimulation, Chemical; D013950:Thymus Gland / Q000033:anatomy & histology / Q000187:drug effects*; D013997:Time Factors; D014945:Wound Healing / Q000187:drug effects*
D000970:Antineoplastic Agents; D013141:Spiro Compounds
Vliianie spirazidina na obshchuiu nespetsificheskuiu rezistentnost' organizma.